TrialAmerican journal of Alzheimer's disease and other dementias2012

Subgroup analysis of US and non-US patients in a global study of high-dose donepezil (23 mg) in moderate and severe Alzheimer's disease.

Stephen Salloway et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.